DGAP-PVR:
STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
|
DGAP Voting Rights Announcement: STADA Arzneimittel AG
STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
31.08.2017 / 15:24
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer
STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany
|
2. Reason for notification
| X |
Acquisition/disposal of shares with voting rights |
| |
Acquisition/disposal of instruments |
| |
Change of breakdown of voting rights |
| X |
Other reason:
Voluntary group notification with triggered threshold on subsidiary level |
3. Details of person subject to the notification obligation
| Name: |
City and country of registered office: |
| Cinven Capital Management (VI) General Partner Limited |
Saint Peter Port, Guernsey
Channel Islands |
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3. Nidda Healthcare GmbH i.Gr.
|
5. Date on which threshold was crossed or reached:
6. Total positions
| |
% of voting rights attached to shares
(total of 7.a.) |
% of voting rights through instruments
(total of 7.b.1 + 7.b.2) |
total of both in %
(7.a. + 7.b.) |
total number of voting rights of issuer |
| Resulting situation |
64.50 % |
0 % |
64.50 % |
62,342,440 |
| Previous notification |
63.76 % |
0 % |
63.76 % |
/ |
7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 21, 22 WpHG)
| ISIN |
absolute |
in % |
| |
direct
(Sec. 21 WpHG) |
indirect
(Sec. 22 WpHG) |
direct
(Sec. 21 WpHG) |
indirect
(Sec. 22 WpHG) |
| DE0007251803 |
|
40,207,789 |
% |
64.50 % |
| Total |
40,207,789 |
64.50 % |
b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG
| Type of instrument |
Expiration or maturity date |
Exercise or conversion period |
Voting rights absolute |
Voting rights in % |
|
|
|
|
% |
| |
|
Total |
|
% |
b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG
| Type of instrument |
Expiration or maturity date |
Exercise or conversion period |
Cash or physical settlement |
Voting rights absolute |
Voting rights in % |
|
|
|
|
|
% |
| |
|
|
Total |
|
% |
8. Information in relation to the person subject to the notification obligation| |
Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). |
| X |
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: |
| Name |
% of voting rights (if at least held 3% or more) |
% of voting rights through instruments (if at least held 5% or more) |
Total of both (if at least held 5% or more) |
| Cinven Capital Management (VI) General Partner Limited |
% |
% |
% |
| Cinven Capital Management (VI) Limited Partnership Incorporated |
% |
% |
% |
| Sixth Cinven Fund (No. 1) Limited Partnership |
% |
% |
% |
| Ciddan S.à r.l. |
% |
% |
% |
| Nidda Topco S.à r.l. |
% |
% |
% |
| Nidda Midco S.à r.l. |
% |
% |
% |
| Nidda German Topco GmbH |
% |
% |
% |
| Nidda German Midco GmbH |
% |
% |
% |
| Nidda BondCo GmbH |
% |
% |
% |
| Nidda Healthcare Holding AG |
% |
% |
% |
| Nidda Healthcare GmbH i.Gr. |
64.50 % |
% |
64.50 % |
| |
|
|
|
| Cinven Capital Management (VI) General Partner Limited |
% |
% |
% |
| Cinven Capital Management (VI) Limited Partnership Incorporated |
% |
% |
% |
| Sixth Cinven Fund (No. 2) Limited Partnership |
% |
% |
% |
| Ciddan S.à r.l. |
% |
% |
% |
| Nidda Topco S.à r.l. |
% |
% |
% |
| Nidda Midco S.à r.l. |
% |
% |
% |
| Nidda German Topco GmbH |
% |
% |
% |
| Nidda German Midco GmbH |
% |
% |
% |
| Nidda BondCo GmbH |
% |
% |
% |
| Nidda Healthcare Holding AG |
% |
% |
% |
| Nidda Healthcare GmbH i.Gr. |
64.50 % |
% |
64.50 % |
| |
|
|
|
| Cinven Capital Management (VI) General Partner Limited |
% |
% |
% |
| Cinven Capital Management (VI) Limited Partnership Incorporated |
% |
% |
% |
| Sixth Cinven Fund (No. 3) Limited Partnership |
% |
% |
% |
| Ciddan S.à r.l. |
% |
% |
% |
| Nidda Topco S.à r.l. |
% |
% |
% |
| Nidda Midco S.à r.l. |
% |
% |
% |
| Nidda German Topco GmbH |
% |
% |
% |
| Nidda German Midco GmbH |
% |
% |
% |
| Nidda BondCo GmbH |
% |
% |
% |
| Nidda Healthcare Holding AG |
% |
% |
% |
| Nidda Healthcare GmbH i.Gr. |
64.50 % |
% |
64.50 % |
| |
|
|
|
| Cinven Capital Management (VI) General Partner Limited |
% |
% |
% |
| Cinven Capital Management (VI) Limited Partnership Incorporated |
% |
% |
% |
| Sixth Cinven Fund (No. 4) Limited Partnership |
% |
% |
% |
| Ciddan S.à r.l. |
% |
% |
% |
| Nidda Topco S.à r.l. |
% |
% |
% |
| Nidda Midco S.à r.l. |
% |
% |
% |
| Nidda German Topco GmbH |
% |
% |
% |
| Nidda German Midco GmbH |
% |
% |
% |
| Nidda BondCo GmbH |
% |
% |
% |
| Nidda Healthcare Holding AG |
% |
% |
% |
| Nidda Healthcare GmbH i.Gr. |
64.50 % |
% |
64.50 % |
| |
|
|
|
9. In case of proxy voting according to Sec. 22 para. 3 WpHG| Date of general meeting: |
|
| Holding position after general meeting: |
% (equals voting rights) |
10. Other explanatory remarks:
31.08.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
|
| Language: |
English |
| Company: |
STADA Arzneimittel AG |
|
Stadastraße 2-18 |
|
61118 Bad Vilbel |
|
Germany |
| Internet: |
www.stada.de |
| |
| End of News |
DGAP News Service |
605835 31.08.2017
Der finanzen.at Ratgeber für Aktien!
ETF-Sparplan